Delaware | 001-31792 | 75-3108137 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01(d). | Financial Statements and Exhibits. |
99.1 | Press release dated October 25, 2011 related to financial results for the quarter ended September 30, 2011. |
99.2 | Quarterly Financial Supplement - 3Q2011. |
CNO Financial Group, Inc. | |||
Date: October 25, 2011 | |||
By: | /s/ John R. Kline | ||
John R. Kline | |||
Senior Vice President and Chief Accounting Officer | |||
Contact: | (News Media) Tony Zehnder +1.312.396.7086 |
(Investors) Scott Galovic +1.317.817.3228 |
• | Net income increased to $196.0 million, compared to $49.4 million in 3Q10 |
• | Net income per diluted share of 66 cents, compared to 17 cents in 3Q10 |
• | $96.1 million of income before net realized investment gains, corporate interest and taxes (“EBIT”) (1), up 2% compared to $93.8 million in 3Q10 |
• | Net operating income (2) of $46.5 million, down 1% compared to $47.1 million in 3Q10 |
• | Net operating income per diluted share: 17 cents, compared to 16 cents in 3Q10 |
• | Total new annualized premium (“NAP”) excluding Private-Fee-For-Service (“PFFS”) and Prescription Drug Plan (“PDP”) (3): $94 million, up 8% from 3Q10 |
• | Net income increased to $309.4 million, compared to $116.4 million in the first nine months of 2010 |
• | Net income per diluted share of $1.05, compared to 42 cents in the first nine months of 2010 |
• | $305.7 million of income before net realized investment gains, corporate interest and taxes (“EBIT”) (1), up 16% compared to $262.7 million in the first nine months of 2010 |
• | Net operating income (2) of $155.9 million, up 20% compared to $130.2 million in the first nine months of 2010 |
• | Net operating income per diluted share: 55 cents, compared to 46 cents in the first nine months of 2010 |
• | NAP excluding PFFS and PDP (3): $272 million, up 1% from the first nine months of 2010 |
• | The consolidated statutory risk-based capital ratio of our insurance subsidiaries increased 8 percentage points to 359% in 3Q11, driven by improved asset quality and statutory earnings of $65.5 million partially offset by $27.4 million of dividend payments to our holding company |
• | Unrestricted cash and investments held by our non-insurance subsidiaries decreased by $65.1 million to $168.9 million during 3Q11, primarily reflecting $39.5 million for share repurchases and $39.5 million of commensurate prepayment of debt, as well as $25.0 million early payment on the Senior Health Note. These outflows were partially offset by the aforementioned dividend payments, surplus debenture interest and management and investment fees |
• | Debt-to-total capital ratio, as defined in our senior secured credit facility (4), reduced to 18.0% from 20.0% at December 31, 2010 |
• | Book value per common share, excluding accumulated other comprehensive income (loss) (5), increased to $17.89 from $16.28 at December 31, 2010 |
Three months ended | |||||||
September 30, | |||||||
2011 | 2010 | ||||||
(Dollars in millions, except per-share data) | |||||||
EBIT (1): | |||||||
Bankers Life | $ | 91.4 | $ | 95.5 | |||
Washington National | 22.1 | 27.2 | |||||
Colonial Penn | 8.1 | 7.8 | |||||
Other CNO Business | 2.0 | (24.4 | ) | ||||
EBIT from business segments | 123.6 | 106.1 | |||||
Corporate Operations, excluding corporate interest expense | (27.5 | ) | (12.3 | ) | |||
EBIT | 96.1 | 93.8 | |||||
Corporate interest expense | (18.7 | ) | (20.0 | ) | |||
Income before net realized investment gains (losses), fair value changes in embedded derivative liabilities and taxes | 77.4 | 73.8 | |||||
Tax expense on operating income | 30.9 | 26.7 | |||||
Net operating income (2) | 46.5 | 47.1 | |||||
Net realized investment gains (losses) (net of related amortization and taxes) | 16.6 | 2.3 | |||||
Fair value changes in embedded derivative liabilities (net of related amortization and taxes) | (9.4 | ) | — | ||||
Loss on extinguishment of debt, net of income taxes | (.7 | ) | — | ||||
Net income before valuation allowance for deferred tax assets | 53.0 | 49.4 | |||||
Decrease in the valuation allowance for deferred tax assets | 143.0 | — | |||||
Net income | $ | 196.0 | $ | 49.4 | |||
Per diluted share: | |||||||
Net operating income | $ | .17 | $ | .16 | |||
Net realized investment gains (losses), net of related amortization and taxes | .05 | .01 | |||||
Fair value changes in embedded derivative liabilities, net of related amortization and taxes | (.03 | ) | — | ||||
Valuation allowance for deferred tax assets | .47 | — | |||||
Net income | $ | .66 | $ | .17 |
Three months ended September 30, 2011 | |||||||||||
Actual results | Significant items | Excluding significant items | |||||||||
EBIT (1): | |||||||||||
Bankers Life | $ | 91.4 | $ | (14.0 | ) | $ | 77.4 | ||||
Washington National | 22.1 | 6.0 | 28.1 | ||||||||
Colonial Penn | 8.1 | — | 8.1 | ||||||||
Other CNO Business | 2.0 | — | 2.0 | ||||||||
EBIT from business segments | 123.6 | (8.0 | ) | 115.6 | |||||||
Corporate Operations, excluding corporate interest expense | (27.5 | ) | 19.3 | (8.2 | ) | ||||||
EBIT (or "pre-tax operating earnings") | 96.1 | 11.3 | 107.4 | ||||||||
Corporate interest expense | (18.7 | ) | — | (18.7 | ) | ||||||
Income before net realized investment gains (losses), fair value changes in embedded derivative liabilities and taxes | 77.4 | 11.3 | 88.7 | ||||||||
Tax expense on operating income | 30.9 | 4.1 | 35.0 | ||||||||
Net operating income | 46.5 | 7.2 | 53.7 | ||||||||
Net realized investment gains (losses) (net of related amortization and taxes) | 16.6 | (16.6 | ) | — | |||||||
Fair value changes in embedded derivative liabilities (net of related amortization and taxes) | (9.4 | ) | 9.4 | — | |||||||
Loss on extinguishment of debt, net of income taxes | (.7 | ) | .7 | — | |||||||
Net income before valuation allowance for deferred tax assets | 53.0 | .7 | 53.7 | ||||||||
Decrease in the valuation allowance for deferred tax assets | 143.0 | (143.0 | ) | — | |||||||
Net income | $ | 196.0 | $ | (142.3 | ) | $ | 53.7 | ||||
Per diluted share: | |||||||||||
Net operating income | $ | .17 | $ | .02 | $ | .19 | |||||
Non-operating items | .49 | (.49 | ) | — | |||||||
Net income | $ | .66 | $ | (.47 | ) | $ | .19 |
(1) | Management believes that an analysis of earnings before net realized investment gains (losses), fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, corporate interest expense, loss on extinguishment of debt and taxes (“EBIT,” a non-GAAP financial measure) provides a clearer comparison of the operating results of the company quarter-over-quarter because these items are unrelated to the company's underlying fundamentals. A reconciliation of EBIT to Net Income applicable to common stock is provided in the tables on pages 2 and 9. |
(2) | Management believes that an analysis of Net income applicable to common stock before: (i) loss on extinguishment of debt, net of income taxes; (ii) net realized investment gains or losses, net of related amortization and income taxes; and (iii) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization and income taxes (“Net operating income,” a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the company's underlying fundamentals. The impact of fair value changes in embedded derivative liabilities caused by interest rate fluctuations was insignificant in prior periods. Prior to June 30, 2011, certain of our trading securities were held to offset the income statement volatility caused by the effect of interest rate fluctuations on the value of embedded derivatives related to our fixed index annuity products. During 2Q2011, these securities were sold. A reconciliation of Net operating income to Net income applicable to common stock is provided in the tables on pages 2 and 9. Additional information concerning this non-GAAP measure is included in our periodic filings with the Securities and Exchange Commission that are available in the “Investors - SEC Filings” section of CNO's website, www.CNOinc.com. |
(3) | Measured by new annualized premium, which includes 6% of annuity and 10% of single premium whole life deposits and 100% of all other premiums. PDP and PFFS sales are not comparable to other sales and are therefore excluded in all periods. |
(4) | The calculation of this non-GAAP measure differs from the corresponding GAAP measure because: (i) debt is defined as par value plus accrued interest and unused letters of credit; and (ii) accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful as the level of such ratio impacts certain provisions in our senior secured credit facility. The corresponding GAAP measures for debt-to-total capital were 15.0% and 18.8% at September 30, 2011 and December 31, 2010, respectively. |
(5) | The calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments. The corresponding GAAP measures for book value per common share were $20.34 and $17.23 at September 30, 2011 and December 31, 2010, respectively. |
September 30, 2011 | December 31, 2010 | ||||||
(unaudited) | |||||||
ASSETS | |||||||
Investments: | |||||||
Fixed maturities, available for sale, at fair value (amortized cost: September 30, 2011 - $21,347.7; December 31, 2010 - $20,155.8) | $ | 23,016.7 | $ | 20,633.9 | |||
Equity securities at fair value (cost: September 30, 2011 - $167.0; December 31, 2010 - $68.2) | 164.3 | 68.1 | |||||
Mortgage loans | 1,648.2 | 1,761.2 | |||||
Policy loans | 279.6 | 284.4 | |||||
Trading securities | 81.8 | 372.6 | |||||
Investments held by securitization entities | 453.5 | 420.9 | |||||
Other invested assets | 190.9 | 240.9 | |||||
Total investments | 25,835.0 | 23,782.0 | |||||
Cash and cash equivalents - unrestricted | 461.9 | 571.9 | |||||
Cash and cash equivalents held by securitization entities | 19.7 | 26.8 | |||||
Accrued investment income | 301.2 | 327.8 | |||||
Present value of future profits | 714.2 | 1,008.6 | |||||
Deferred acquisition costs | 1,444.7 | 1,764.2 | |||||
Reinsurance receivables | 3,131.3 | 3,256.3 | |||||
Income tax assets, net | 687.2 | 839.4 | |||||
Assets held in separate accounts | 15.4 | 17.5 | |||||
Other assets | 314.9 | 305.1 | |||||
Total assets | $ | 32,925.5 | $ | 31,899.6 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
Liabilities: | |||||||
Liabilities for insurance products: | |||||||
Interest-sensitive products | $ | 13,168.2 | $ | 13,194.7 | |||
Traditional products | 10,444.8 | 10,307.6 | |||||
Claims payable and other policyholder funds | 985.5 | 968.7 | |||||
Liabilities related to separate accounts | 15.4 | 17.5 | |||||
Other liabilities | 576.9 | 496.3 | |||||
Investment borrowings | 1,509.1 | 1,204.1 | |||||
Borrowings related to variable interest entities | 405.6 | 386.9 | |||||
Notes payable – direct corporate obligations | 871.2 | 998.5 | |||||
Total liabilities | 27,976.7 | 27,574.3 | |||||
Commitments and Contingencies | |||||||
Shareholders' equity: | |||||||
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: September 30, 2011 – 243,247,260; December 31, 2010 – 251,084,174) | 2.4 | 2.5 | |||||
Additional paid-in capital | 4,379.4 | 4,424.2 | |||||
Accumulated other comprehensive income | 597.3 | 238.3 | |||||
Accumulated deficit | (30.3 | ) | (339.7 | ) | |||
Total shareholders' equity | 4,948.8 | 4,325.3 | |||||
Total liabilities and shareholders' equity | $ | 32,925.5 | $ | 31,899.6 |
Three months ended | Nine months ended | ||||||||||||||
September 30, | September 30, | ||||||||||||||
2011 | 2010 | 2011 | 2010 | ||||||||||||
Revenues: | |||||||||||||||
Insurance policy income | $ | 673.5 | $ | 674.5 | $ | 2,020.3 | $ | 2,007.0 | |||||||
Net investment income: | |||||||||||||||
General account assets | 338.2 | 326.5 | 1,016.5 | 962.8 | |||||||||||
Policyholder and reinsurer accounts and other special-purpose portfolios | (54.9 | ) | 43.3 | (14.4 | ) | 44.6 | |||||||||
Realized investment gains (losses): | |||||||||||||||
Net realized investment gains, excluding impairment losses | 33.5 | 28.1 | 64.9 | 54.7 | |||||||||||
Other-than-temporary impairment losses: | |||||||||||||||
Total other-than-temporary impairment losses | (2.9 | ) | (22.8 | ) | (26.3 | ) | (69.8 | ) | |||||||
Portion of other-than-temporary impairment losses recognized in accumulated other comprehensive income | — | (1.7 | ) | — | (2.9 | ) | |||||||||
Net impairment losses recognized | (2.9 | ) | (24.5 | ) | (26.3 | ) | (72.7 | ) | |||||||
Total realized gains (losses) | 30.6 | 3.6 | 38.6 | (18.0 | ) | ||||||||||
Fee revenue and other income | 4.9 | 4.6 | 12.5 | 11.7 | |||||||||||
Total revenues | 992.3 | 1,052.5 | 3,073.5 | 3,008.1 | |||||||||||
Benefits and expenses: | |||||||||||||||
Insurance policy benefits | 661.0 | 700.0 | 2,028.6 | 2,050.0 | |||||||||||
Interest expense | 27.9 | 28.4 | 86.0 | 84.6 | |||||||||||
Amortization | 87.2 | 118.6 | 325.4 | 317.8 | |||||||||||
Loss on extinguishment of debt | 1.1 | — | 3.1 | 2.7 | |||||||||||
Other operating costs and expenses | 127.6 | 128.2 | 367.1 | 370.8 | |||||||||||
Total benefits and expenses | 904.8 | 975.2 | 2,810.2 | 2,825.9 | |||||||||||
Income before income taxes | 87.5 | 77.3 | 263.3 | 182.2 | |||||||||||
Income tax expense: | |||||||||||||||
Tax expense on period income | 34.5 | 27.9 | 96.9 | 65.8 | |||||||||||
Valuation allowance for deferred tax assets | (143.0 | ) | — | (143.0 | ) | — | |||||||||
Net income | $ | 196.0 | $ | 49.4 | $ | 309.4 | $ | 116.4 | |||||||
Earnings per common share: | |||||||||||||||
Basic: | |||||||||||||||
Weighted average shares outstanding | 246,965,000 | 251,045,000 | 249,673,000 | 250,942,000 | |||||||||||
Net income | $ | .79 | $ | .20 | $ | 1.24 | $ | .46 | |||||||
Diluted: | |||||||||||||||
Weighted average shares outstanding | 302,708,000 | 306,040,000 | 306,085,000 | 300,256,000 | |||||||||||
Net income | $ | .66 | $ | .17 | $ | 1.05 | $ | .42 |
Nine months ended | |||||||
September 30, | |||||||
2011 | 2010 | ||||||
EBIT (1): | |||||||
Bankers Life | $ | 240.0 | $ | 212.7 | |||
Washington National | 70.0 | 75.9 | |||||
Colonial Penn | 21.1 | 20.7 | |||||
Other CNO Business | 13.9 | (17.5 | ) | ||||
EBIT from business segments | 345.0 | 291.8 | |||||
Corporate Operations, excluding corporate interest expense | (39.3 | ) | (29.1 | ) | |||
EBIT | 305.7 | 262.7 | |||||
Corporate interest expense | (58.6 | ) | (59.3 | ) | |||
Income before net realized investment gains (losses), fair value changes in embedded derivative liabilities and taxes | 247.1 | 203.4 | |||||
Tax expense on operating income | 91.2 | 73.2 | |||||
Net operating income (2) | 155.9 | 130.2 | |||||
Net realized investment gains (losses) (net of related amortization and taxes) | 21.9 | (12.0 | ) | ||||
Fair value changes in embedded derivative liabilities (net of related amortization and taxes) | (9.4 | ) | — | ||||
Loss on extinguishment of debt, net of income taxes | (2.0 | ) | (1.8 | ) | |||
Net income before valuation allowance for deferred tax assets | 166.4 | 116.4 | |||||
Decrease in the valuation allowance for deferred tax assets | 143.0 | — | |||||
Net income | $ | 309.4 | $ | 116.4 | |||
Per diluted share: | |||||||
Net operating income | $ | .55 | $ | .46 | |||
Net realized investment gains (losses), net of related amortization and taxes | .07 | (.04 | ) | ||||
Fair value changes in embedded derivative liabilities, net of related amortization and taxes | (.03 | ) | — | ||||
Loss on extinguishment of debt, net of income taxes | (.01 | ) | — | ||||
Valuation allowance for deferred tax assets | .47 | — | |||||
Net income | $ | 1.05 | $ | .42 |
Three months ended | |||||||
September 30, | |||||||
2011 | 2010 | ||||||
Bankers Life segment: | |||||||
Annuity | $ | 264.1 | $ | 265.8 | |||
Medicare supplement and other supplemental health | 328.0 | 333.4 | |||||
Life | 65.5 | 54.8 | |||||
Total collected premiums | $ | 657.6 | $ | 654.0 | |||
Washington National segment: | |||||||
Medicare supplement and other supplemental health | $ | 141.2 | $ | 140.7 | |||
Life | 4.1 | 3.8 | |||||
Total collected premiums | $ | 145.3 | $ | 144.5 | |||
Colonial Penn segment: | |||||||
Life | $ | 49.2 | $ | 46.9 | |||
Supplemental health | 1.4 | 1.5 | |||||
Total collected premiums | $ | 50.6 | $ | 48.4 | |||
Other CNO Business segment: | |||||||
Annuity | $ | 3.3 | $ | 3.6 | |||
Other health | 6.7 | 7.6 | |||||
Life | 44.0 | 47.8 | |||||
Total collected premiums | $ | 54.0 | $ | 59.0 |
Three months ended | |||||
September 30, | |||||
2011 | 2010 | ||||
Bankers Life segment: | |||||
Medicare Supplement: | |||||
Earned premium | $179 million | $178 million | |||
Benefit ratio(a) | 68.4 | % | 69.5 | % | |
PDP and PFFS: | |||||
Earned premium | $13 million | $19 million | |||
Benefit ratio(a) | 72.3 | % | 29.5 | % | |
Long-Term Care: | |||||
Earned premium | $142 million | $147 million | |||
Benefit ratio(a) | 109.7 | % | 114.2 | % | |
Interest-adjusted benefit ratio (a non-GAAP measure)(b) | 65.5 | % | 73.2 | % | |
Washington National segment: | |||||
Medicare Supplement: | |||||
Earned premium | $33 million | $39 million | |||
Benefit ratio(a) | 69.9 | % | 67.0 | % | |
Supplemental health: | |||||
Earned premium | $108 million | $101 million | |||
Benefit ratio(a) | 82.4 | % | 81.3 | % | |
Interest-adjusted benefit ratio (a non-GAAP measure)(b) | 53.9 | % | 50.5 | % | |
Other CNO Business segment: | |||||
Long-Term Care: | |||||
Earned premium | $7 million | $7 million | |||
Benefit ratio(a) | 227.5 | % | 201.7 | % | |
Interest-adjusted benefit ratio (a non-GAAP measure)(b) | 126.1 | % | 116.9 | % |
(a) | The benefit ratio is calculated by dividing the related product's insurance policy benefits by insurance policy income. |
(b) | The interest-adjusted benefit ratio (a non-GAAP measure) is calculated by dividing the product's insurance policy benefits less interest income on the accumulated assets backing the insurance liabilities by insurance policy income. Interest income is an important factor in measuring the performance of longer duration health products. The net cash flows generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases), which will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in the change in reserve will be partially offset by interest income earned on the accumulated assets. The interest-adjusted benefit ratio reflects the interest income offset. Since interest income is an important factor in measuring the performance of these products, management believes a benefit ratio, which includes the effect of interest income, is useful in analyzing product performance. Additional information concerning this non-GAAP measure is included in our periodic filings with the Securities and Exchange Commission that are available in the “Investors - SEC Filings” section of CNO Financial's website, www.CNOinc.com. |
Quarterly Financial Supplement - | |||||
3Q2011 | |||||
October 25, 2011 | |||||
Table of Contents | Page | |||
Consolidated balance sheet | 3 | |||
Consolidated statement of operations | 4 | |||
Earnings per share analysis | 5 | |||
Computation of weighted average shares outstanding | 6 | |||
Analyses of income before taxes and selected data: | ||||
Bankers Life | 7-8 | |||
Washington National | 9-10 | |||
Colonial Penn | 11 | |||
Other CNO Business | 12-13 | |||
Premiums collected on insurance products: | ||||
Bankers Life | 14 | |||
Washington National | 15 | |||
Colonial Penn | 16 | |||
Other CNO Business | 17 | |||
New annualized premiums | 18 | |||
Statutory information | 19 | |||
Notes | 20 |
CNO Financial Group, Inc. | ||||||||||||||||||||||||
Consolidated balance sheet (in millions) | Mar-10 | Jun-10 | Sep-10 | Dec-10 | Mar-11 | Jun-11 | Sep-11 | Dec-11 | ||||||||||||||||
Assets | ||||||||||||||||||||||||
Investments: | ||||||||||||||||||||||||
Fixed maturities, available for sale, at fair value | $ | 18,813.8 | $ | 19,935.7 | $ | 21,007.5 | $ | 20,633.9 | $ | 20,852.2 | $ | 21,622.9 | $ | 23,016.7 | ||||||||||
Equity securities at fair value | 31.1 | 31.0 | 41.1 | 68.1 | 105.4 | 129.6 | 164.3 | |||||||||||||||||
Mortgage loans | 1,936.6 | 1,948.1 | 1,825.6 | 1,761.2 | 1,751.3 | 1,752.8 | 1,648.2 | |||||||||||||||||
Policy loans | 294.0 | 292.9 | 290.9 | 284.4 | 281.6 | 279.5 | 279.6 | |||||||||||||||||
Trading securities | 332.0 | 360.7 | 389.7 | 372.6 | 403.1 | 83.5 | 81.8 | |||||||||||||||||
Investments held by variable interest entities | 511.7 | 478.4 | 454.8 | 420.9 | 401.6 | 414.0 | 453.5 | |||||||||||||||||
Securities lending collateral | 147.4 | 77.6 | — | — | — | — | — | |||||||||||||||||
Other invested assets | 236.3 | 167.2 | 189.5 | 240.9 | 272.1 | 252.2 | 190.9 | |||||||||||||||||
Total investments | 22,302.9 | 23,291.6 | 24,199.1 | 23,782.0 | 24,067.3 | 24,534.5 | 25,835.0 | |||||||||||||||||
Cash and cash equivalents - unrestricted | 321.1 | 323.7 | 548.8 | 571.9 | 424.6 | 580.2 | 461.9 | |||||||||||||||||
Cash and cash equivalents held by variable interest entities | 24.3 | 13.5 | 18.3 | 26.8 | 27.1 | 25.3 | 19.7 | |||||||||||||||||
Accrued investment income | 334.0 | 323.1 | 345.3 | 327.8 | 336.7 | 314.3 | 301.2 | |||||||||||||||||
Present value of future profits | 1,133.2 | 1,077.3 | 1,028.3 | 1,008.6 | 970.1 | 936.5 | 714.2 | |||||||||||||||||
Deferred acquisition costs | 1,788.0 | 1,700.0 | 1,612.7 | 1,764.2 | 1,766.1 | 1,762.6 | 1,444.7 | |||||||||||||||||
Reinsurance receivables | 3,444.1 | 3,357.2 | 3,315.7 | 3,256.3 | 3,219.0 | 3,172.5 | 3,131.3 | |||||||||||||||||
Income tax assets, net | 1,021.9 | 769.0 | 536.7 | 839.4 | 798.9 | 703.5 | 687.2 | |||||||||||||||||
Assets held in separate accounts | 17.0 | 15.6 | 16.7 | 17.5 | 18.1 | 17.4 | 15.4 | |||||||||||||||||
Other assets | 398.4 | 349.8 | 352.0 | 305.1 | 439.9 | 349.8 | 314.9 | |||||||||||||||||
Total assets | $ | 30,784.9 | $ | 31,220.8 | $ | 31,973.6 | $ | 31,899.6 | $ | 32,067.8 | $ | 32,396.6 | $ | 32,925.5 | ||||||||||
Liabilities | ||||||||||||||||||||||||
Liabilities for insurance products: | ||||||||||||||||||||||||
Interest-sensitive products | $ | 13,217.7 | $ | 13,177.8 | $ | 13,217.6 | $ | 13,194.7 | $ | 13,161.3 | $ | 13,152.8 | $ | 13,168.2 | ||||||||||
Traditional products | 10,137.6 | 10,199.7 | 10,253.0 | 10,307.6 | 10,357.9 | 10,424.4 | 10,444.8 | |||||||||||||||||
Claims payable and other policyholder funds | 969.4 | 946.0 | 939.4 | 968.7 | 979.0 | 978.0 | 985.5 | |||||||||||||||||
Liabilities related to separate accounts | 17.0 | 15.6 | 16.7 | 17.5 | 18.1 | 17.4 | 15.4 | |||||||||||||||||
Other liabilities | 583.6 | 683.6 | 833.9 | 496.3 | 643.1 | 703.7 | 576.9 | |||||||||||||||||
Investment borrowings | 454.5 | 454.2 | 653.9 | 1,204.1 | 1,203.8 | 1,305.3 | 1,509.1 | |||||||||||||||||
Borrowings related to variable interest entities | 495.4 | 449.7 | 425.0 | 386.9 | 354.4 | 317.3 | 405.6 | |||||||||||||||||
Securities lending payable | 152.4 | 82.0 | — | — | — | — | — | |||||||||||||||||
Notes payable - direct corporate obligations | 1,037.2 | 1,029.4 | 1,029.8 | 998.5 | 949.8 | 934.5 | 871.2 | |||||||||||||||||
Total liabilities | 27,064.8 | 27,038.0 | 27,369.3 | 27,574.3 | 27,667.4 | 27,833.4 | 27,976.7 | |||||||||||||||||
Shareholders' equity | ||||||||||||||||||||||||
Common stock | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.4 | |||||||||||||||||
Additional paid-in capital | 4,411.0 | 4,418.8 | 4,421.6 | 4,424.2 | 4,426.1 | 4,414.3 | 4,379.4 | |||||||||||||||||
Accumulated deficit | (590.4 | ) | (557.3 | ) | (507.9 | ) | (339.7 | ) | (285.8 | ) | (226.3 | ) | (30.3 | ) | ||||||||||
Total shareholders' equity before accumulated other comprehensive income (loss) | 3,823.1 | 3,864.0 | 3,916.2 | 4,087.0 | 4,142.8 | 4,190.5 | 4,351.5 | |||||||||||||||||
Accumulated other comprehensive income (loss) | (103.0 | ) | 318.8 | 688.1 | 238.3 | 257.6 | 372.7 | 597.3 | ||||||||||||||||
Total shareholders' equity | 3,720.1 | 4,182.8 | 4,604.3 | 4,325.3 | 4,400.4 | 4,563.2 | 4,948.8 | |||||||||||||||||
Total liabilities and shareholders' equity | $ | 30,784.9 | $ | 31,220.8 | $ | 31,973.6 | $ | 31,899.6 | $ | 32,067.8 | $ | 32,396.6 | $ | 32,925.5 | ||||||||||
1Q10 | 2Q10 | 3Q10 | 4Q10 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | |||||||||||||||||
Book value per share at period-end (1) (2) | $ | 15.24 | $ | 15.39 | $ | 15.60 | $ | 16.28 | $ | 16.48 | $ | 16.80 | $ | 17.89 | ||||||||||
Book value per share assuming conversion of convertible securities (1) (3) | $ | 13.68 | $ | 13.52 | $ | 13.70 | $ | 14.23 | $ | 14.37 | $ | 14.58 | $ | 15.49 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Consolidated statement of operations (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Revenues | ||||||||||||||||||||||||||
Insurance policy income | $ | 664.6 | $ | 667.9 | $ | 674.5 | $ | 663.0 | $ | 2,670.0 | $ | 667.2 | $ | 679.6 | $ | 673.5 | ||||||||||
Net investment income (loss): | ||||||||||||||||||||||||||
General account assets | 315.2 | 321.1 | 326.5 | 332.2 | 1,295.0 | 336.1 | 342.2 | 338.2 | ||||||||||||||||||
Policyholder and reinsurer accounts and other special-purpose portfolios | 24.0 | (22.7 | ) | 43.3 | 27.3 | 71.9 | 37.4 | 3.1 | (54.9 | ) | ||||||||||||||||
Realized investment gains (losses): | ||||||||||||||||||||||||||
Net realized investment gains, excluding impairment losses | 15.4 | 11.2 | 28.1 | 125.3 | 180.0 | 18.4 | 13.0 | 33.5 | ||||||||||||||||||
Other-than-temporary impairment losses: | ||||||||||||||||||||||||||
Total other-than-temporary impairment losses | (17.7 | ) | (29.3 | ) | (22.8 | ) | (77.0 | ) | (146.8 | ) | (13.3 | ) | (10.1 | ) | (2.9 | ) | ||||||||||
Portion of other-than-temporary impairment losses recognized in accumulated other comprehensive income (loss) | (2.6 | ) | 1.4 | (1.7 | ) | (0.1 | ) | (3.0 | ) | — | — | — | ||||||||||||||
Net impairment losses recognized | (20.3 | ) | (27.9 | ) | (24.5 | ) | (77.1 | ) | (149.8 | ) | (13.3 | ) | (10.1 | ) | (2.9 | ) | ||||||||||
Total realized gains (losses) | (4.9 | ) | (16.7 | ) | 3.6 | 48.2 | 30.2 | 5.1 | 2.9 | 30.6 | ||||||||||||||||
Fee revenue and other income | 3.5 | 3.6 | 4.6 | 5.1 | 16.8 | 3.4 | 4.2 | 4.9 | ||||||||||||||||||
Total revenues | 1,002.4 | 953.2 | 1,052.5 | 1,075.8 | 4,083.9 | 1,049.2 | 1,032.0 | 992.3 | ||||||||||||||||||
Benefits and expenses | ||||||||||||||||||||||||||
Insurance policy benefits | 699.0 | 651.0 | 700.0 | 673.7 | 2,723.7 | 683.2 | 684.4 | 661.0 | ||||||||||||||||||
Interest expense | 27.5 | 28.7 | 28.4 | 28.6 | 113.2 | 29.2 | 28.9 | 27.9 | ||||||||||||||||||
Amortization | 102.6 | 96.6 | 118.6 | 126.0 | 443.8 | 136.7 | 101.5 | 87.2 | ||||||||||||||||||
Loss on extinguishment of debt | 1.8 | 0.9 | — | 4.1 | 6.8 | 1.4 | 0.6 | 1.1 | ||||||||||||||||||
Other operating costs and expenses | 118.4 | 124.2 | 128.2 | 132.1 | 502.9 | 115.1 | 124.4 | 127.6 | ||||||||||||||||||
Total benefits and expenses | 949.3 | 901.4 | 975.2 | 964.5 | 3,790.4 | 965.6 | 939.8 | 904.8 | ||||||||||||||||||
Income before income taxes | 53.1 | 51.8 | 77.3 | 111.3 | 293.5 | 83.6 | 92.2 | 87.5 | ||||||||||||||||||
Income tax expense on period income | 19.2 | 18.7 | 27.9 | 38.1 | 103.9 | 29.7 | 32.7 | 34.5 | ||||||||||||||||||
Valuation allowance for deferred tax assets | — | — | — | (95.0 | ) | (95.0 | ) | — | — | (143.0 | ) | |||||||||||||||
Net income | $ | 33.9 | $ | 33.1 | $ | 49.4 | $ | 168.2 | $ | 284.6 | $ | 53.9 | $ | 59.5 | $ | 196.0 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Earnings per share analysis ($ in millions, except per share amounts) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Income (loss) before net realized investment losses, net of related amortization and income taxes: | ||||||||||||||||||||||||||
Bankers Life | $ | 53.2 | $ | 64.0 | $ | 95.5 | $ | 71.4 | $ | 284.1 | $ | 63.9 | $ | 84.7 | $ | 91.4 | ||||||||||
Washington National | 27.6 | 21.1 | 27.2 | 28.7 | 104.6 | 25.2 | 22.7 | 22.1 | ||||||||||||||||||
Colonial Penn | 5.3 | 7.6 | 7.8 | 5.8 | 26.5 | 5.4 | 7.6 | 8.1 | ||||||||||||||||||
Other CNO Business | (1.9 | ) | 8.8 | (24.4 | ) | 6.0 | (11.5 | ) | 7.1 | 4.8 | 2.0 | |||||||||||||||
Corporate operations: | ||||||||||||||||||||||||||
Interest expense on debt | (19.5 | ) | (19.8 | ) | (20.0 | ) | (20.0 | ) | (79.3 | ) | (20.6 | ) | (19.3 | ) | (18.7 | ) | ||||||||||
Loss on extinguishment of debt | (1.8 | ) | (0.9 | ) | — | (4.1 | ) | (6.8 | ) | (1.4 | ) | (0.6 | ) | (1.1 | ) | |||||||||||
Other corporate expenses, net | (5.0 | ) | (11.8 | ) | (12.3 | ) | (13.7 | ) | (42.8 | ) | (0.5 | ) | (11.3 | ) | (27.5 | ) | ||||||||||
Net realized investment gains (losses), net of related amortization | (4.8 | ) | (17.2 | ) | 3.5 | 37.2 | 18.7 | 4.5 | 3.6 | 25.7 | ||||||||||||||||
Fair value changes in embedded derivative liabilities, net of related amortization | — | — | — | — | — | — | — | (14.5 | ) | |||||||||||||||||
Income before taxes | 53.1 | 51.8 | 77.3 | 111.3 | 293.5 | 83.6 | 92.2 | 87.5 | ||||||||||||||||||
Taxes | 19.2 | 18.7 | 27.9 | 38.1 | 103.9 | 29.7 | 32.7 | 34.5 | ||||||||||||||||||
Valuation allowance for deferred tax assets | — | — | — | (95.0 | ) | (95.0 | ) | — | — | (143.0 | ) | |||||||||||||||
Net income | $ | 33.9 | $ | 33.1 | $ | 49.4 | $ | 168.2 | $ | 284.6 | $ | 53.9 | $ | 59.5 | $ | 196.0 | ||||||||||
Diluted earnings per share | $ | 0.13 | $ | 0.12 | $ | 0.17 | $ | 0.56 | $ | 0.99 | $ | 0.19 | $ | 0.21 | $ | 0.66 | ||||||||||
Net realized investment gains (losses), net of related amortization and taxes | (0.01 | ) | (0.04 | ) | 0.01 | 0.08 | 0.04 | 0.01 | 0.01 | 0.05 | ||||||||||||||||
Fair value changes in embedded derivative liabilities, net of related amortization and taxes | — | — | — | — | — | — | — | (0.03 | ) | |||||||||||||||||
Valuation allowance for deferred tax assets | — | — | — | 0.31 | 0.31 | — | — | 0.47 | ||||||||||||||||||
Loss on extinguishment of debt | — | — | — | (0.01 | ) | (0.01 | ) | — | — | — | ||||||||||||||||
Diluted earnings per share, excluding net realized investment gains (losses), fair value changes in embedded derivative liabilities, valuation allowance for deferred tax assets and loss on extinguishment of debt | $ | 0.14 | $ | 0.16 | $ | 0.16 | $ | 0.18 | $ | 0.65 | $ | 0.18 | $ | 0.20 | $ | 0.17 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||
Computation of weighted average shares outstanding | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||
(000s) | ||||||||||||||||||
Basic | ||||||||||||||||||
Shares outstanding, beginning of period | 250,786.2 | 250,929.8 | 251,044.7 | 251,046.4 | 250,786.2 | 251,084.2 | 251,404.9 | 249,415.2 | ||||||||||
Weighted average shares issued during the period: | ||||||||||||||||||
Shares repurchased | — | — | — | — | — | — | (590.3 | ) | (2,511.6 | ) | ||||||||
Shares issued under stock option and restricted stock plans | 2.3 | 67.8 | 0.1 | 18.2 | 240.0 | 52.6 | 118.5 | 61.8 | ||||||||||
Shares withheld for the payment of the exercise price of stock options and taxes | (0.7 | ) | (3.4 | ) | — | (0.5 | ) | (53.5 | ) | (16.3 | ) | — | (0.3 | ) | ||||
Weighted average basic shares outstanding during the period | 250,787.8 | 250,994.2 | 251,044.8 | 251,064.1 | 250,972.7 | 251,120.5 | 250,933.1 | 246,965.1 | ||||||||||
Basic shares outstanding, end of period | 250,929.8 | 251,044.7 | 251,046.4 | 251,084.2 | 251,084.2 | 251,404.9 | 249,415.2 | 243,247.3 | ||||||||||
Diluted | ||||||||||||||||||
Weighted average basic shares outstanding | 250,787.8 | 250,994.2 | 251,044.8 | 251,064.1 | 250,972.7 | 251,120.5 | 250,933.1 | 246,965.1 | ||||||||||
Common stock equivalent shares related to: | ||||||||||||||||||
Convertible debentures | 39,532.4 | 49,793.3 | 53,363.6 | 53,366.9 | 49,014.1 | 53,366.9 | 53,366.9 | 53,366.9 | ||||||||||
Stock option and restricted stock plans | 1,760.3 | 1,860.6 | 1,631.2 | 2,231.1 | 1,870.8 | 2,748.3 | 3,035.8 | 2,352.9 | ||||||||||
Warrants | — | — | — | — | — | 262.4 | 712.4 | 22.9 | ||||||||||
Weighted average diluted shares outstanding during the period | 292,080.5 | 302,648.1 | 306,039.6 | 306,662.1 | 301,857.6 | 307,498.1 | 308,048.2 | 302,707.8 | ||||||||||
Diluted shares outstanding, end of period | 296,498.0 | 306,268.9 | 306,044.5 | 306,682.1 | 306,682.1 | 307,782.4 | 306,530.3 | 298,990.0 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Bankers Life | ||||||||||||||||||||||||||
Analysis of income before taxes (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Insurance policy income | $ | 396.2 | $ | 400.7 | $ | 405.1 | $ | 394.2 | $ | 1,596.2 | $ | 400.0 | $ | 409.6 | $ | 404.6 | ||||||||||
Net investment income (loss): | ||||||||||||||||||||||||||
General account invested assets | 172.2 | 177.0 | 182.4 | 187.7 | 719.3 | 191.3 | 196.5 | 194.3 | ||||||||||||||||||
Fixed index products | 12.1 | (15.3 | ) | 21.9 | 13.9 | 32.6 | 18.3 | 0.4 | (36.3 | ) | ||||||||||||||||
Other special-purpose portfolios | 1.6 | (1.2 | ) | 4.2 | 2.4 | 7.0 | — | — | — | |||||||||||||||||
Net realized investment gains (losses) | (3.0 | ) | (10.3 | ) | 18.3 | 57.1 | 62.1 | 6.6 | (1.8 | ) | 26.5 | |||||||||||||||
Fee revenue and other income | 2.3 | 2.7 | 3.6 | 4.2 | 12.8 | 2.3 | 3.3 | 3.6 | ||||||||||||||||||
Total revenues | 581.4 | 553.6 | 635.5 | 659.5 | 2,430.0 | 618.5 | 608.0 | 592.7 | ||||||||||||||||||
Insurance policy benefits | 350.6 | 344.2 | 341.8 | 339.9 | 1,376.5 | 337.6 | 351.3 | 333.6 | ||||||||||||||||||
Insurance policy benefits - fair value changes in embedded derivative liabilities | — | — | — | — | — | — | — | 30.7 | ||||||||||||||||||
Amounts added to policyholder account balances: | ||||||||||||||||||||||||||
Annuity products and interest-sensitive life products other than fixed index products | 43.8 | 44.1 | 43.3 | 44.1 | 175.3 | 40.8 | 40.5 | 40.0 | ||||||||||||||||||
Fixed index products | 22.1 | (5.6 | ) | 17.0 | 22.0 | 55.5 | 26.4 | 17.1 | (13.0 | ) | ||||||||||||||||
Amortization related to operations | 67.0 | 70.6 | 76.4 | 76.5 | 290.5 | 101.9 | 69.7 | 67.2 | ||||||||||||||||||
Amortization related to net realized investment gains (losses) | 0.5 | (0.5 | ) | 1.4 | 8.8 | 10.2 | 1.0 | (0.4 | ) | 3.9 | ||||||||||||||||
Amortization related to fair value changes in embedded derivative liabilities | — | — | — | — | — | — | — | (16.4 | ) | |||||||||||||||||
Interest expense on investment borrowings | — | — | — | 1.0 | 1.0 | 1.2 | 1.1 | 1.2 | ||||||||||||||||||
Other operating costs and expenses | 47.7 | 46.6 | 43.2 | 47.5 | 185.0 | 40.1 | 45.4 | 45.8 | ||||||||||||||||||
Total benefits and expenses | 531.7 | 499.4 | 523.1 | 539.8 | 2,094.0 | 549.0 | 524.7 | 493.0 | ||||||||||||||||||
Income before income taxes | $ | 49.7 | $ | 54.2 | $ | 112.4 | $ | 119.7 | $ | 336.0 | $ | 69.5 | $ | 83.3 | $ | 99.7 | ||||||||||
Health underwriting margins (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Medicare supplement: | ||||||||||||||||||||||||||
Earned premium | $ | 178.8 | $ | 178.5 | $ | 178.2 | $ | 177.4 | $ | 712.9 | $ | 181.0 | $ | 179.5 | $ | 179.2 | ||||||||||
Benefit ratio | 72.8 | % | 70.7 | % | 69.5 | % | 70.7 | % | 70.9 | % | 67.2 | % | 69.8 | % | 68.4 | % | ||||||||||
Underwriting margin (earned premium less policy benefits) | $ | 48.6 | $ | 52.3 | $ | 54.4 | $ | 52.0 | $ | 207.3 | $ | 59.3 | $ | 54.2 | $ | 56.7 | ||||||||||
PDP: | ||||||||||||||||||||||||||
Earned premium | $ | 18.0 | $ | 19.7 | $ | 19.3 | $ | 10.8 | $ | 67.8 | $ | 14.4 | $ | 16.7 | $ | 12.9 | ||||||||||
Benefit ratio | 88.7 | % | 89.8 | % | 64.4 | % | 60.7 | % | 77.7 | % | 89.5 | % | 88.6 | % | 76.1 | % | ||||||||||
Underwriting margin (earned premium less policy benefits) | $ | 2.0 | $ | 2.0 | $ | 6.9 | $ | 4.2 | $ | 15.1 | $ | 1.5 | $ | 1.9 | $ | 3.1 | ||||||||||
PFFS: | ||||||||||||||||||||||||||
Earned premium | $ | (0.1 | ) | $ | (0.3 | ) | $ | (0.4 | ) | $ | 0.2 | $ | (0.6 | ) | $ | — | $ | 3.6 | $ | — | ||||||
Benefit ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||
Underwriting margin (earned premium less policy benefits) | $ | 5.0 | $ | 4.0 | $ | 6.5 | $ | 2.0 | $ | 17.5 | $ | 0.7 | $ | 3.7 | $ | 0.5 | ||||||||||
Long-term care: | ||||||||||||||||||||||||||
Earned premium | $ | 149.1 | $ | 144.6 | $ | 146.8 | $ | 145.4 | $ | 585.9 | $ | 144.4 | $ | 143.4 | $ | 142.0 | ||||||||||
Benefit ratio before interest income on reserves | 114.4 | % | 113.0 | % | 114.2 | % | 113.3 | % | 113.7 | % | 113.4 | % | 115.0 | % | 109.7 | % | ||||||||||
Interest-adjusted benefit ratio | 75.2 | % | 71.9 | % | 73.2 | % | 71.5 | % | 73.0 | % | 70.8 | % | 71.6 | % | 65.5 | % | ||||||||||
Underwriting margin (earned premium plus interest income on reserves less policy benefits) | $ | 36.9 | $ | 40.6 | $ | 39.4 | $ | 41.5 | $ | 158.4 | $ | 42.2 | $ | 40.7 | $ | 49.1 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Bankers Life | ||||||||||||||||||||||||||
Average liabilities for insurance products (in millions) (continued) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Annuities: | ||||||||||||||||||||||||||
Mortality based | $ | 251.8 | $ | 250.7 | $ | 249.4 | $ | 248.5 | $ | 250.1 | $ | 245.9 | $ | 243.1 | $ | 240.0 | ||||||||||
Fixed index | 1,685.0 | 1,769.7 | 1,871.3 | 2,008.3 | 1,833.6 | 2,147.7 | 2,268.3 | 2,412.9 | ||||||||||||||||||
Deposit based | 4,905.3 | 4,905.5 | 4,905.2 | 4,882.8 | 4,899.7 | 4,832.4 | 4,793.2 | 4,750.5 | ||||||||||||||||||
Medicare supplement and other supplemental health | 4,275.6 | 4,337.4 | 4,376.8 | 4,431.4 | 4,355.3 | 4,489.6 | 4,529.9 | 4,564.0 | ||||||||||||||||||
Life: | ||||||||||||||||||||||||||
Interest sensitive | 407.8 | 412.2 | 414.0 | 417.6 | 412.9 | 420.5 | 425.2 | 431.8 | ||||||||||||||||||
Non-interest sensitive | 331.4 | 346.9 | 363.4 | 379.5 | 355.3 | 397.8 | 416.8 | 437.7 | ||||||||||||||||||
Total average liabilities for insurance products, net of reinsurance ceded | $ | 11,856.9 | $ | 12,022.4 | $ | 12,180.1 | $ | 12,368.1 | $ | 12,106.9 | $ | 12,533.9 | $ | 12,676.5 | $ | 12,836.9 | ||||||||||
Present value of future profits (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Balance, beginning of period | $ | 569.5 | $ | 539.1 | $ | 495.3 | $ | 465.7 | $ | 569.5 | $ | 467.2 | $ | 442.7 | $ | 422.0 | ||||||||||
Amortization related to operations | (22.5 | ) | (21.5 | ) | (19.1 | ) | (16.9 | ) | (80.0 | ) | (24.6 | ) | (16.9 | ) | (14.3 | ) | ||||||||||
Amortization related to net realized investment (gains) losses | — | — | (0.1 | ) | (0.4 | ) | (0.5 | ) | (0.1 | ) | 0.1 | (0.2 | ) | |||||||||||||
Adjustment related to unrealized (gain) or loss on fixed maturities, available for sale | (7.9 | ) | (22.3 | ) | (10.4 | ) | 18.8 | (21.8 | ) | 0.2 | (3.9 | ) | (198.6 | ) | ||||||||||||
Balance, end of period | $ | 539.1 | $ | 495.3 | $ | 465.7 | $ | 467.2 | $ | 467.2 | $ | 442.7 | $ | 422.0 | $ | 208.9 | ||||||||||
Deferred acquisition costs (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Balance, beginning of period | $ | 1,179.1 | $ | 1,171.3 | $ | 1,089.6 | $ | 1,011.4 | $ | 1,179.1 | $ | 1,149.5 | $ | 1,146.2 | $ | 1,139.9 | ||||||||||
Deferred acquisition expenses | 72.0 | 78.5 | 77.5 | 77.7 | 305.7 | 76.6 | 76.6 | 81.9 | ||||||||||||||||||
Amortization related to operations | (44.5 | ) | (49.1 | ) | (57.3 | ) | (59.6 | ) | (210.5 | ) | (77.3 | ) | (52.8 | ) | (52.9 | ) | ||||||||||
Amortization related to net realized investment (gains) losses | (0.5 | ) | 0.5 | (1.3 | ) | (8.4 | ) | (9.7 | ) | (0.9 | ) | 0.3 | (3.7 | ) | ||||||||||||
Amortization related to fair value changes in embedded derivative liabilities | — | — | — | — | — | — | — | 16.4 | ||||||||||||||||||
Adjustment related to unrealized (gain) or loss on fixed maturities, available for sale | (34.8 | ) | (111.6 | ) | (97.1 | ) | 128.4 | (115.1 | ) | (1.7 | ) | (30.4 | ) | (345.2 | ) | |||||||||||
Balance, end of period | $ | 1,171.3 | $ | 1,089.6 | $ | 1,011.4 | $ | 1,149.5 | $ | 1,149.5 | $ | 1,146.2 | $ | 1,139.9 | $ | 836.4 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Washington National | ||||||||||||||||||||||||||
Analysis of income before taxes (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Insurance policy income | $ | 145.4 | $ | 144.7 | $ | 144.9 | $ | 146.0 | $ | 581.0 | $ | 145.4 | $ | 146.6 | $ | 145.9 | ||||||||||
Net investment income (loss): | ||||||||||||||||||||||||||
General account invested assets | 45.5 | 45.8 | 46.2 | 46.7 | 184.2 | 46.3 | 46.7 | 47.3 | ||||||||||||||||||
Trading account income related to reinsurer accounts | 0.8 | 1.1 | 1.6 | (1.0 | ) | 2.5 | 0.3 | 0.7 | 2.6 | |||||||||||||||||
Change in value of embedded derivatives related to modified coinsurance agreements | (0.9 | ) | (1.0 | ) | (1.4 | ) | 2.0 | (1.3 | ) | (0.3 | ) | (0.7 | ) | (2.6 | ) | |||||||||||
Net realized investment gains (losses) | (1.2 | ) | — | (2.3 | ) | (3.9 | ) | (7.4 | ) | (0.5 | ) | (0.5 | ) | 1.6 | ||||||||||||
Fee revenue and other income | 0.3 | 0.2 | 0.3 | 0.3 | 1.1 | 0.3 | 0.2 | 0.4 | ||||||||||||||||||
Total revenues | 189.9 | 190.8 | 189.3 | 190.1 | 760.1 | 191.5 | 193.0 | 195.2 | ||||||||||||||||||
Insurance policy benefits | 112.5 | 116.7 | 112.4 | 109.0 | 450.6 | 112.2 | 118.3 | 119.0 | ||||||||||||||||||
Amortization related to operations | 14.8 | 13.1 | 14.4 | 14.6 | 56.9 | 16.1 | 14.0 | 13.9 | ||||||||||||||||||
Interest expense on investment borrowings | — | — | — | — | — | — | — | 0.2 | ||||||||||||||||||
Other operating costs and expenses | 36.2 | 39.9 | 37.6 | 41.7 | 155.4 | 38.5 | 38.5 | 38.4 | ||||||||||||||||||
Total benefits and expenses | 163.5 | 169.7 | 164.4 | 165.3 | 662.9 | 166.8 | 170.8 | 171.5 | ||||||||||||||||||
Income before income taxes | $ | 26.4 | $ | 21.1 | $ | 24.9 | $ | 24.8 | $ | 97.2 | $ | 24.7 | $ | 22.2 | $ | 23.7 | ||||||||||
Health underwriting margins (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Medicare supplement: | ||||||||||||||||||||||||||
Earned premium | $ | 41.6 | $ | 40.2 | $ | 39.1 | $ | 37.5 | $ | 158.4 | $ | 35.5 | $ | 34.9 | $ | 33.5 | ||||||||||
Benefit ratio | 65.7 | % | 65.8 | % | 67.0 | % | 70.9 | % | 67.3 | % | 66.3 | % | 71.1 | % | 69.9 | % | ||||||||||
Underwriting margin (earned premium less policy benefits) | $ | 14.2 | $ | 13.8 | $ | 12.9 | $ | 10.9 | $ | 51.8 | $ | 12.0 | $ | 10.1 | $ | 10.1 | ||||||||||
Supplemental health: | ||||||||||||||||||||||||||
Earned premium | $ | 98.0 | $ | 99.1 | $ | 100.6 | $ | 103.1 | $ | 400.8 | $ | 104.7 | $ | 106.9 | $ | 107.6 | ||||||||||
Benefit ratio before interest income on reserves | 82.3 | % | 83.2 | % | 81.3 | % | 75.0 | % | 80.4 | % | 78.7 | % | 82.7 | % | 82.4 | % | ||||||||||
Interest-adjusted benefit ratio | 49.4 | % | 52.0 | % | 50.5 | % | 45.0 | % | 49.2 | % | 49.1 | % | 54.1 | % | 53.9 | % | ||||||||||
Underwriting margin (earned premium plus interest income on reserves less policy benefits) | $ | 49.6 | $ | 47.6 | $ | 49.7 | $ | 56.8 | $ | 203.7 | $ | 53.3 | $ | 49.1 | $ | 49.6 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Washington National | ||||||||||||||||||||||||||
Average liabilities for insurance products (in millions) (continued) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Medicare supplement and other supplemental health | $ | 2,530.1 | $ | 2,485.5 | $ | 2,432.4 | $ | 2,432.5 | $ | 2,470.1 | $ | 2,434.6 | $ | 2,437.1 | $ | 2,436.9 | ||||||||||
Non-interest sensitive life | 206.8 | 206.5 | 207.8 | 205.7 | 206.7 | 205.2 | 202.2 | 198.7 | ||||||||||||||||||
Total average liabilities for insurance products, net of reinsurance ceded | $ | 2,736.9 | $ | 2,692.0 | $ | 2,640.2 | $ | 2,638.2 | $ | 2,676.8 | $ | 2,639.8 | $ | 2,639.3 | $ | 2,635.6 | ||||||||||
Present value of future profits (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Balance, beginning of period | $ | 455.1 | $ | 447.6 | $ | 440.7 | $ | 433.8 | $ | 455.1 | $ | 426.9 | $ | 418.5 | $ | 411.5 | ||||||||||
Amortization related to operations | (7.5 | ) | (6.9 | ) | (6.9 | ) | (6.9 | ) | (28.2 | ) | (8.4 | ) | (7.0 | ) | (5.5 | ) | ||||||||||
Balance, end of period | $ | 447.6 | $ | 440.7 | $ | 433.8 | $ | 426.9 | $ | 426.9 | $ | 418.5 | $ | 411.5 | $ | 406.0 | ||||||||||
Deferred acquisition costs (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Balance, beginning of period | $ | 185.4 | $ | 190.2 | $ | 196.4 | $ | 206.7 | $ | 185.4 | $ | 212.3 | $ | 216.8 | $ | 222.3 | ||||||||||
Deferred acquisition expenses | 12.1 | 12.4 | 17.8 | 13.3 | 55.6 | 12.2 | 12.5 | 13.0 | ||||||||||||||||||
Amortization related to operations | (7.3 | ) | (6.2 | ) | (7.5 | ) | (7.7 | ) | (28.7 | ) | (7.7 | ) | (7.0 | ) | (8.4 | ) | ||||||||||
Balance, end of period | $ | 190.2 | $ | 196.4 | $ | 206.7 | $ | 212.3 | $ | 212.3 | $ | 216.8 | $ | 222.3 | $ | 226.9 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Colonial Penn | ||||||||||||||||||||||||||
Analysis of income before taxes (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Insurance policy income | $ | 48.2 | $ | 49.3 | $ | 48.8 | $ | 48.6 | $ | 194.9 | $ | 50.3 | $ | 50.9 | $ | 50.8 | ||||||||||
Net investment income on general account invested assets | 9.7 | 9.7 | 9.9 | 10.0 | 39.3 | 10.3 | 10.5 | 10.1 | ||||||||||||||||||
Net realized investment gains | 0.5 | — | 2.0 | 4.1 | 6.6 | 1.1 | 0.2 | 3.5 | ||||||||||||||||||
Fee revenue and other income | 0.2 | 0.1 | 0.2 | 0.2 | 0.7 | 0.2 | 0.2 | 0.2 | ||||||||||||||||||
Total revenues | 58.6 | 59.1 | 60.9 | 62.9 | 241.5 | 61.9 | 61.8 | 64.6 | ||||||||||||||||||
Insurance policy benefits | 36.4 | 35.2 | 36.1 | 36.1 | 143.8 | 38.5 | 37.8 | 35.7 | ||||||||||||||||||
Amounts added to annuity and interest-sensitive life product account balances | 0.3 | 0.2 | 0.3 | 0.2 | 1.0 | 0.2 | 0.2 | 0.3 | ||||||||||||||||||
Amortization related to operations | 8.7 | 8.8 | 7.0 | 8.8 | 33.3 | 9.0 | 8.6 | 9.3 | ||||||||||||||||||
Other operating costs and expenses | 7.4 | 7.3 | 7.7 | 7.9 | 30.3 | 7.7 | 7.4 | 7.7 | ||||||||||||||||||
Total benefits and expenses | 52.8 | 51.5 | 51.1 | 53.0 | 208.4 | 55.4 | 54.0 | 53.0 | ||||||||||||||||||
Income before income taxes | $ | 5.8 | $ | 7.6 | $ | 9.8 | $ | 9.9 | $ | 33.1 | $ | 6.5 | $ | 7.8 | $ | 11.6 | ||||||||||
Average liabilities for insurance products (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Annuities - mortality based | $ | 79.9 | $ | 79.3 | $ | 79.2 | $ | 79.2 | $ | 79.4 | $ | 78.5 | $ | 77.8 | $ | 77.3 | ||||||||||
Supplemental health | 18.3 | 17.7 | 17.5 | 17.1 | 17.6 | 16.6 | 16.3 | 16.1 | ||||||||||||||||||
Life: | ||||||||||||||||||||||||||
Interest sensitive | 21.9 | 21.6 | 21.1 | 20.7 | 21.3 | 20.7 | 20.5 | 20.2 | ||||||||||||||||||
Non-interest sensitive | 576.6 | 578.2 | 580.3 | 583.6 | 579.7 | 586.7 | 588.7 | 590.2 | ||||||||||||||||||
Total average liabilities for insurance products, net of reinsurance ceded | $ | 696.7 | $ | 696.8 | $ | 698.1 | $ | 700.6 | $ | 698.0 | $ | 702.5 | $ | 703.3 | $ | 703.8 | ||||||||||
Present value of future profits (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Balance, beginning of period | $ | 92.4 | $ | 89.4 | $ | 86.6 | $ | 84.0 | $ | 92.4 | $ | 81.7 | $ | 79.1 | $ | 76.9 | ||||||||||
Amortization related to operations | (3.0 | ) | (2.8 | ) | (2.6 | ) | (2.3 | ) | (10.7 | ) | (2.6 | ) | (2.2 | ) | (2.0 | ) | ||||||||||
Balance, end of period | $ | 89.4 | $ | 86.6 | $ | 84.0 | $ | 81.7 | $ | 81.7 | $ | 79.1 | $ | 76.9 | $ | 74.9 | ||||||||||
Deferred acquisition costs (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Balance, beginning of period | $ | 199.8 | $ | 211.0 | $ | 217.0 | $ | 223.7 | $ | 199.8 | $ | 226.5 | $ | 238.5 | $ | 246.6 | ||||||||||
Deferred acquisition expenses | 16.9 | 12.0 | 11.1 | 9.3 | 49.3 | 18.4 | 14.5 | 17.5 | ||||||||||||||||||
Amortization related to operations | (5.7 | ) | (6.0 | ) | (4.4 | ) | (6.5 | ) | (22.6 | ) | (6.4 | ) | (6.4 | ) | (7.3 | ) | ||||||||||
Balance, end of period | $ | 211.0 | $ | 217.0 | $ | 223.7 | $ | 226.5 | $ | 226.5 | $ | 238.5 | $ | 246.6 | $ | 256.8 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Other CNO Business | ||||||||||||||||||||||||||
Analysis of income (loss) before taxes (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Insurance policy income | $ | 74.8 | $ | 73.2 | $ | 75.7 | $ | 74.2 | $ | 297.9 | $ | 71.5 | $ | 72.5 | $ | 72.2 | ||||||||||
Net investment income (loss): | ||||||||||||||||||||||||||
General account invested assets | 87.8 | 88.5 | 88.0 | 87.8 | 352.1 | 88.2 | 87.6 | 85.4 | ||||||||||||||||||
Fixed index products | 3.9 | (6.5 | ) | 6.2 | 6.2 | 9.8 | 5.0 | (0.9 | ) | (8.4 | ) | |||||||||||||||
Trading account income related to policyholder accounts | 0.9 | (1.6 | ) | 2.3 | 1.1 | 2.7 | 1.5 | — | (2.4 | ) | ||||||||||||||||
Net realized investment gains (losses) | 0.1 | (5.0 | ) | (13.0 | ) | (9.7 | ) | (27.6 | ) | (1.0 | ) | 1.1 | 3.0 | |||||||||||||
Total revenues | 167.5 | 148.6 | 159.2 | 159.6 | 634.9 | 165.2 | 160.3 | 149.8 | ||||||||||||||||||
Insurance policy benefits | 90.3 | 84.3 | 110.4 | 82.6 | 367.6 | 88.8 | 85.9 | 86.7 | ||||||||||||||||||
Insurance policy benefits - fair value changes in embedded derivative liabilities | — | — | — | — | — | — | — | 3.2 | ||||||||||||||||||
Amounts added to policyholder account balances: | ||||||||||||||||||||||||||
Annuity products and interest-sensitive life products other than fixed index products | 32.4 | 31.4 | 32.4 | 31.4 | 127.6 | 31.6 | 30.3 | 28.9 | ||||||||||||||||||
Fixed index products | 10.6 | 0.5 | 6.3 | 8.4 | 25.8 | 7.1 | 3.0 | (4.1 | ) | |||||||||||||||||
Amortization related to operations | 12.2 | 3.6 | 20.7 | 15.1 | 51.6 | 9.1 | 9.9 | 11.3 | ||||||||||||||||||
Amortization related to net realized investment gains (losses) | (0.6 | ) | 1.0 | (1.3 | ) | 2.2 | 1.3 | (0.4 | ) | (0.3 | ) | 1.0 | ||||||||||||||
Amortization related to fair value changes in embedded derivative liabilities | — | — | — | — | — | — | — | (3.0 | ) | |||||||||||||||||
Interest expense on investment borrowings | 5.0 | 5.0 | 5.1 | 4.9 | 20.0 | 4.9 | 5.0 | 5.3 | ||||||||||||||||||
Other operating costs and expenses | 18.8 | 20.0 | 21.7 | 20.9 | 81.4 | 17.6 | 20.3 | 16.7 | ||||||||||||||||||
Total benefits and expenses | 168.7 | 145.8 | 195.3 | 165.5 | 675.3 | 158.7 | 154.1 | 146.0 | ||||||||||||||||||
Income (loss) before income taxes | $ | (1.2 | ) | $ | 2.8 | $ | (36.1 | ) | $ | (5.9 | ) | $ | (40.4 | ) | $ | 6.5 | $ | 6.2 | $ | 3.8 | ||||||
Health underwriting margins (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Long-term care: | ||||||||||||||||||||||||||
Earned premium | $ | 7.7 | $ | 7.5 | $ | 7.5 | $ | 7.2 | $ | 29.9 | $ | 7.3 | $ | 7.0 | $ | 6.9 | ||||||||||
Benefit ratio before interest income on reserves | 187.2 | % | 212.9 | % | 201.7 | % | 243.0 | % | 210.8 | % | 235.7 | % | 205.8 | % | 227.5 | % | ||||||||||
Interest-adjusted benefit ratio | 96.8 | % | 128.0 | % | 116.9 | % | 155.1 | % | 123.8 | % | 148.0 | % | 106.4 | % | 126.1 | % | ||||||||||
Underwriting margin (earned premium plus interest income on reserves less policy benefits) | $ | 0.2 | $ | (2.1 | ) | $ | (1.2 | ) | $ | (4.0 | ) | $ | (7.1 | ) | $ | (3.5 | ) | $ | (0.5 | ) | $ | (1.8 | ) | |||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Other CNO Business | ||||||||||||||||||||||||||
Average liabilities for insurance products (in millions) (continued) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Annuities: | ||||||||||||||||||||||||||
Mortality based | $ | 212.0 | $ | 210.9 | $ | 209.8 | $ | 209.2 | $ | 210.5 | $ | 207.8 | $ | 205.9 | $ | 218.9 | ||||||||||
Fixed index | 743.6 | 728.1 | 705.5 | 678.0 | 713.8 | 652.1 | 632.1 | 607.6 | ||||||||||||||||||
Deposit based | 620.0 | 659.6 | 705.0 | 698.8 | 670.9 | 692.0 | 687.4 | 666.5 | ||||||||||||||||||
Separate accounts | 17.1 | 16.3 | 16.2 | 17.1 | 16.7 | 17.8 | 17.7 | 16.4 | ||||||||||||||||||
Other health | 480.9 | 480.1 | 479.4 | 479.8 | 480.0 | 481.8 | 481.9 | 481.3 | ||||||||||||||||||
Life: | ||||||||||||||||||||||||||
Interest sensitive | 2,607.2 | 2,593.7 | 2,581.0 | 2,560.1 | 2,585.5 | 2,527.4 | 2,506.1 | 2,484.6 | ||||||||||||||||||
Non-interest sensitive | 844.9 | 839.9 | 831.2 | 820.5 | 834.1 | 805.6 | 790.9 | 780.6 | ||||||||||||||||||
Total average liabilities for insurance products, net of reinsurance ceded | $ | 5,525.7 | $ | 5,528.6 | $ | 5,528.1 | $ | 5,463.5 | $ | 5,511.5 | $ | 5,384.5 | $ | 5,322.0 | $ | 5,255.9 | ||||||||||
Present value of future profits (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Balance, beginning of period | $ | 58.9 | $ | 57.1 | $ | 54.7 | $ | 44.8 | $ | 58.9 | $ | 32.8 | $ | 29.8 | $ | 26.1 | ||||||||||
Amortization related to operations | (1.3 | ) | (1.6 | ) | (9.7 | ) | (7.1 | ) | (19.7 | ) | (2.4 | ) | (2.2 | ) | (1.1 | ) | ||||||||||
Amortization related to net realized investment (gains) losses | — | — | 0.1 | — | 0.1 | — | — | — | ||||||||||||||||||
Adjustment related to unrealized (gain) or loss on fixed maturities, available for sale | (0.5 | ) | (0.8 | ) | (0.3 | ) | (4.9 | ) | (6.5 | ) | (0.6 | ) | (1.5 | ) | (0.6 | ) | ||||||||||
Balance, end of period | $ | 57.1 | $ | 54.7 | $ | 44.8 | $ | 32.8 | $ | 32.8 | $ | 29.8 | $ | 26.1 | $ | 24.4 | ||||||||||
Deferred acquisition costs (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Balance, beginning of period | $ | 226.6 | $ | 215.5 | $ | 197.0 | $ | 170.9 | $ | 226.6 | $ | 175.9 | $ | 164.6 | $ | 153.8 | ||||||||||
Deferred acquisition expenses | 8.0 | 2.3 | 1.8 | 2.1 | 14.2 | 2.1 | 2.1 | 1.3 | ||||||||||||||||||
Other adjustments | — | (3.9 | ) | (6.8 | ) | — | (10.7 | ) | — | — | — | |||||||||||||||
Amortization related to operations | (10.9 | ) | (2.0 | ) | (11.0 | ) | (8.0 | ) | (31.9 | ) | (6.7 | ) | (7.7 | ) | (10.2 | ) | ||||||||||
Amortization related to net realized investment (gains) losses | 0.6 | (1.0 | ) | 1.2 | (2.2 | ) | (1.4 | ) | 0.4 | 0.3 | (1.0 | ) | ||||||||||||||
Amortization related to fair value changes in embedded derivative liabilities | — | — | — | — | — | — | — | 3.0 | ||||||||||||||||||
Adjustment related to unrealized (gain) or loss on fixed maturities, available for sale | (8.8 | ) | (13.9 | ) | (11.3 | ) | 13.1 | (20.9 | ) | (7.1 | ) | (5.5 | ) | (22.3 | ) | |||||||||||
Balance, end of period | $ | 215.5 | $ | 197.0 | $ | 170.9 | $ | 175.9 | $ | 175.9 | $ | 164.6 | $ | 153.8 | $ | 124.6 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Bankers Life | ||||||||||||||||||||||||||
Premiums collected on insurance products (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Annuities | ||||||||||||||||||||||||||
Fixed index (first-year) | $ | 104.0 | $ | 146.9 | $ | 146.3 | $ | 180.5 | $ | 577.7 | $ | 148.2 | $ | 163.9 | $ | 208.0 | ||||||||||
Other fixed rate (first-year) | 119.1 | 133.1 | 118.4 | 52.9 | 423.5 | 73.1 | 94.1 | 55.1 | ||||||||||||||||||
Other fixed rate (renewal) | 1.1 | 1.1 | 1.1 | 1.0 | 4.3 | 0.9 | 1.1 | 1.0 | ||||||||||||||||||
Subtotal - other fixed rate annuities | 120.2 | 134.2 | 119.5 | 53.9 | 427.8 | 74.0 | 95.2 | 56.1 | ||||||||||||||||||
Total annuities | 224.2 | 281.1 | 265.8 | 234.4 | 1,005.5 | 222.2 | 259.1 | 264.1 | ||||||||||||||||||
Health | ||||||||||||||||||||||||||
Medicare supplement (first-year) | 27.2 | 29.4 | 29.3 | 30.5 | 116.4 | 25.1 | 24.7 | 24.5 | ||||||||||||||||||
Medicare supplement (renewal) | 149.4 | 139.4 | 140.8 | 151.8 | 581.4 | 153.7 | 144.3 | 146.8 | ||||||||||||||||||
Subtotal - Medicare supplement | 176.6 | 168.8 | 170.1 | 182.3 | 697.8 | 178.8 | 169.0 | 171.3 | ||||||||||||||||||
Long-term care (first-year) | 4.8 | 5.5 | 5.7 | 6.2 | 22.2 | 6.1 | 6.0 | 5.9 | ||||||||||||||||||
Long-term care (renewal) | 144.7 | 141.1 | 139.3 | 137.3 | 562.4 | 138.8 | 136.9 | 131.9 | ||||||||||||||||||
Subtotal - long-term care | 149.5 | 146.6 | 145.0 | 143.5 | 584.6 | 144.9 | 142.9 | 137.8 | ||||||||||||||||||
PDP and PFFS (first-year) | 1.4 | 0.7 | 0.6 | 1.0 | 3.7 | 0.4 | 0.2 | 0.6 | ||||||||||||||||||
PDP and PFFS (renewal) | 16.7 | 13.4 | 15.0 | 17.6 | 62.7 | 10.6 | 14.4 | 15.6 | ||||||||||||||||||
Subtotal - PDP and PFFS | 18.1 | 14.1 | 15.6 | 18.6 | 66.4 | 11.0 | 14.6 | 16.2 | ||||||||||||||||||
Other health (first-year) | 0.6 | 0.5 | 0.5 | 0.5 | 2.1 | 0.4 | 0.3 | 0.4 | ||||||||||||||||||
Other health (renewal) | 2.3 | 2.4 | 2.2 | 2.3 | 9.2 | 2.5 | 2.3 | 2.3 | ||||||||||||||||||
Subtotal - other health | 2.9 | 2.9 | 2.7 | 2.8 | 11.3 | 2.9 | 2.6 | 2.7 | ||||||||||||||||||
Total health | 347.1 | 332.4 | 333.4 | 347.2 | 1,360.1 | 337.6 | 329.1 | 328.0 | ||||||||||||||||||
Life insurance | ||||||||||||||||||||||||||
First-year | 20.2 | 24.8 | 25.8 | 26.9 | 97.7 | 24.7 | 29.4 | 30.9 | ||||||||||||||||||
Renewal | 26.3 | 27.3 | 29.0 | 29.3 | 111.9 | 31.7 | 32.6 | 34.6 | ||||||||||||||||||
Total life insurance | 46.5 | 52.1 | 54.8 | 56.2 | 209.6 | 56.4 | 62.0 | 65.5 | ||||||||||||||||||
Collections on insurance products | ||||||||||||||||||||||||||
Total first-year premium collections on insurance products | 277.3 | 340.9 | 326.6 | 298.5 | 1,243.3 | 278.0 | 318.6 | 325.4 | ||||||||||||||||||
Total renewal premium collections on insurance products | 340.5 | 324.7 | 327.4 | 339.3 | 1,331.9 | 338.2 | 331.6 | 332.2 | ||||||||||||||||||
Total collections on insurance products | $ | 617.8 | $ | 665.6 | $ | 654.0 | $ | 637.8 | $ | 2,575.2 | $ | 616.2 | $ | 650.2 | $ | 657.6 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Washington National | ||||||||||||||||||||||||||
Premiums collected on insurance products (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Health | ||||||||||||||||||||||||||
Medicare supplement (first-year) | $ | 1.2 | $ | 1.1 | $ | 0.7 | $ | 0.8 | $ | 3.8 | $ | 0.6 | $ | 0.5 | $ | 0.4 | ||||||||||
Medicare supplement (renewal) | 39.5 | 37.6 | 37.2 | 36.7 | 151.0 | 34.7 | 32.6 | 31.5 | ||||||||||||||||||
Subtotal - Medicare supplement | 40.7 | 38.7 | 37.9 | 37.5 | 154.8 | 35.3 | 33.1 | 31.9 | ||||||||||||||||||
Supplemental health (first-year) | 12.5 | 13.1 | 13.0 | 13.4 | 52.0 | 13.2 | 13.7 | 13.2 | ||||||||||||||||||
Supplemental health (renewal) | 87.1 | 87.1 | 88.5 | 90.8 | 353.5 | 93.7 | 95.2 | 95.2 | ||||||||||||||||||
Subtotal - supplemental health | 99.6 | 100.2 | 101.5 | 104.2 | 405.5 | 106.9 | 108.9 | 108.4 | ||||||||||||||||||
Other health (all renewal) | 1.1 | 1.0 | 1.3 | 1.2 | 4.6 | 1.0 | 0.8 | 0.9 | ||||||||||||||||||
Total health | 141.4 | 139.9 | 140.7 | 142.9 | 564.9 | 143.2 | 142.8 | 141.2 | ||||||||||||||||||
Life insurance | ||||||||||||||||||||||||||
First-year | 0.2 | 0.1 | 0.1 | 0.4 | 0.8 | 0.4 | 0.3 | 0.4 | ||||||||||||||||||
Renewal | 4.2 | 3.7 | 3.7 | 3.8 | 15.4 | 3.9 | 3.6 | 3.7 | ||||||||||||||||||
Total life insurance | 4.4 | 3.8 | 3.8 | 4.2 | 16.2 | 4.3 | 3.9 | 4.1 | ||||||||||||||||||
Collections on insurance products | ||||||||||||||||||||||||||
Total first-year premium collections on insurance products | 13.9 | 14.3 | 13.8 | 14.6 | 56.6 | 14.2 | 14.5 | 14.0 | ||||||||||||||||||
Total renewal premium collections on insurance products | 131.9 | 129.4 | 130.7 | 132.5 | 524.5 | 133.3 | 132.2 | 131.3 | ||||||||||||||||||
Total collections on insurance products | $ | 145.8 | $ | 143.7 | $ | 144.5 | $ | 147.1 | $ | 581.1 | $ | 147.5 | $ | 146.7 | $ | 145.3 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Colonial Penn | ||||||||||||||||||||||||||
Premiums collected on insurance products (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Life insurance | ||||||||||||||||||||||||||
First-year | $ | 7.9 | $ | 8.1 | $ | 8.1 | $ | 8.2 | $ | 32.3 | $ | 8.7 | $ | 8.6 | $ | 8.9 | ||||||||||
Renewal | 39.4 | 38.6 | 38.8 | 38.6 | 155.4 | 40.7 | 39.9 | 40.3 | ||||||||||||||||||
Total life insurance | 47.3 | 46.7 | 46.9 | 46.8 | 187.7 | 49.4 | 48.5 | 49.2 | ||||||||||||||||||
Health (all renewal) | ||||||||||||||||||||||||||
Medicare supplement | 1.5 | 1.6 | 1.4 | 1.5 | 6.0 | 1.3 | 1.4 | 1.3 | ||||||||||||||||||
Other health | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | 0.2 | 0.1 | 0.1 | ||||||||||||||||||
Total health | 1.6 | 1.7 | 1.5 | 1.6 | 6.4 | 1.5 | 1.5 | 1.4 | ||||||||||||||||||
Collections on insurance products | ||||||||||||||||||||||||||
Total first-year premium collections on insurance products | 7.9 | 8.1 | 8.1 | 8.2 | 32.3 | 8.7 | 8.6 | 8.9 | ||||||||||||||||||
Total renewal premium collections on insurance products | 41.0 | 40.3 | 40.3 | 40.2 | 161.8 | 42.2 | 41.4 | 41.7 | ||||||||||||||||||
Total collections on insurance products | $ | 48.9 | $ | 48.4 | $ | 48.4 | $ | 48.4 | $ | 194.1 | $ | 50.9 | $ | 50.0 | $ | 50.6 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Other CNO Business | ||||||||||||||||||||||||||
Premiums collected on insurance products (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Annuities | ||||||||||||||||||||||||||
Fixed index (first-year) | $ | 3.5 | $ | 2.0 | $ | 2.4 | $ | 2.4 | $ | 10.3 | $ | 2.7 | $ | 2.7 | $ | 2.2 | ||||||||||
Fixed index (renewal) | 1.2 | 1.5 | 0.9 | 1.0 | 4.6 | 0.9 | 1.4 | 0.8 | ||||||||||||||||||
Subtotal - fixed index annuities | 4.7 | 3.5 | 3.3 | 3.4 | 14.9 | 3.6 | 4.1 | 3.0 | ||||||||||||||||||
Other fixed rate (first-year) | 0.2 | 0.5 | 0.2 | — | 0.9 | 0.4 | 1.6 | 0.1 | ||||||||||||||||||
Other fixed rate (renewal) | 0.2 | 0.2 | 0.1 | 0.1 | 0.6 | 0.2 | 0.2 | 0.2 | ||||||||||||||||||
Subtotal - other fixed rate annuities | 0.4 | 0.7 | 0.3 | 0.1 | 1.5 | 0.6 | 1.8 | 0.3 | ||||||||||||||||||
Total annuities | 5.1 | 4.2 | 3.6 | 3.5 | 16.4 | 4.2 | 5.9 | 3.3 | ||||||||||||||||||
Health | ||||||||||||||||||||||||||
Long-term care (all renewal) | 7.7 | 7.5 | 7.1 | 6.9 | 29.2 | 7.4 | 7.0 | 6.5 | ||||||||||||||||||
Other health (all renewal) | 0.7 | 0.7 | 0.5 | 0.6 | 2.5 | 0.2 | 0.2 | 0.2 | ||||||||||||||||||
Total health | 8.4 | 8.2 | 7.6 | 7.5 | 31.7 | 7.6 | 7.2 | 6.7 | ||||||||||||||||||
Life insurance | ||||||||||||||||||||||||||
First-year | 0.6 | 0.7 | 0.6 | 0.4 | 2.3 | 0.4 | 0.9 | 0.3 | ||||||||||||||||||
Renewal | 49.6 | 46.2 | 47.2 | 46.3 | 189.3 | 46.0 | 48.0 | 43.7 | ||||||||||||||||||
Total life insurance | 50.2 | 46.9 | 47.8 | 46.7 | 191.6 | 46.4 | 48.9 | 44.0 | ||||||||||||||||||
Collections on insurance products | ||||||||||||||||||||||||||
Total first-year premium collections on insurance products | 4.3 | 3.2 | 3.2 | 2.8 | 13.5 | 3.5 | 5.2 | 2.6 | ||||||||||||||||||
Total renewal premium collections on insurance products | 59.4 | 56.1 | 55.8 | 54.9 | 226.2 | 54.7 | 56.8 | 51.4 | ||||||||||||||||||
Total collections on insurance products | $ | 63.7 | $ | 59.3 | $ | 59.0 | $ | 57.7 | $ | 239.7 | $ | 58.2 | $ | 62.0 | $ | 54.0 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
New Annualized Premiums ("NAP") (in millions) | ||||||||||||||||||||||||||
Bankers Life | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11 | 4Q11 | 2011 | ||||||||||||||||
Medicare supplement | $ | 19.4 | $ | 21.0 | $ | 16.0 | $ | 31.8 | $ | 88.2 | $ | 18.3 | $ | 18.6 | $ | 19.4 | ||||||||||
Life | 15.8 | 17.3 | 16.3 | 15.9 | 65.3 | 16.6 | 18.6 | 18.2 | ||||||||||||||||||
Long-term care | 8.6 | 8.7 | 7.2 | 6.7 | 31.2 | 6.9 | 7.3 | 7.3 | ||||||||||||||||||
Annuity | 13.7 | 17.0 | 15.8 | 14.2 | 60.7 | 13.4 | 15.6 | 15.9 | ||||||||||||||||||
Subtotal Bankers Life | 57.5 | 64.0 | 55.3 | 68.6 | 245.4 | 55.2 | 60.1 | 60.8 | ||||||||||||||||||
Washington National | ||||||||||||||||||||||||||
Supplemental health | 14.6 | 17.5 | 18.0 | 17.5 | 67.6 | 15.7 | 17.9 | 18.6 | ||||||||||||||||||
Medicare supplement | 1.1 | 0.7 | 0.4 | 0.8 | 3.0 | 0.5 | 0.4 | 0.3 | ||||||||||||||||||
Life | 0.7 | 0.7 | 0.8 | 0.7 | 2.9 | 0.8 | 0.8 | 0.9 | ||||||||||||||||||
Annuity | 0.3 | 0.2 | 0.2 | 0.2 | 0.9 | 0.2 | 0.3 | 0.2 | ||||||||||||||||||
Subtotal Washington National | 16.7 | 19.1 | 19.4 | 19.2 | 74.4 | 17.2 | 19.4 | 20.0 | ||||||||||||||||||
Colonial Penn | ||||||||||||||||||||||||||
Graded Life | 13.1 | 12.2 | 11.5 | 9.5 | 46.3 | 13.6 | 12.8 | 12.7 | ||||||||||||||||||
Total NAP | $ | 87.3 | $ | 95.3 | $ | 86.2 | $ | 97.3 | $ | 366.1 | $ | 86.0 | $ | 92.3 | $ | 93.5 | ||||||||||
CNO Financial Group, Inc. | ||||||||||||||||||||||||||
Statutory information - consolidated basis (4) (in millions) | 1Q10 | 2Q10 | 3Q10 | 4Q10 | 2010 | 1Q11 | 2Q11 | 3Q11(*) | 4Q11 | 2011 | ||||||||||||||||
Net gain from operations before interest expense and federal income taxes | $ | 55.6 | $ | 66.0 | $ | 97.3 | $ | 109.1 | $ | 328.0 | $ | 114.0 | $ | 92.9 | $ | 91.9 | ||||||||||
Interest expense on surplus debentures held by parent company | 12.0 | 12.2 | 12.2 | 12.3 | 48.7 | 12.0 | 12.2 | 22.7 | ||||||||||||||||||
Net gain from operations before federal income taxes | 43.6 | 53.8 | 85.1 | 96.8 | 279.3 | 102.0 | 80.7 | 69.2 | ||||||||||||||||||
Federal income tax expense (benefit) | 4.3 | 7.6 | 1.6 | 4.3 | 17.8 | 0.6 | 2.0 | 3.7 | ||||||||||||||||||
Net gain from operations before net realized capital gains (losses) | 39.3 | 46.2 | 83.5 | 92.5 | 261.5 | 101.4 | 78.7 | 65.5 | ||||||||||||||||||
Net realized capital gains (losses) | (13.5 | ) | (10.2 | ) | (10.3 | ) | (45.6 | ) | (79.6 | ) | (15.0 | ) | 2.4 | 10.5 | ||||||||||||
Net income | $ | 25.8 | $ | 36.0 | $ | 73.2 | $ | 46.9 | $ | 181.9 | $ | 86.4 | $ | 81.1 | $ | 76.0 | ||||||||||
Capital and surplus | $ | 1,418.5 | $ | 1,434.7 | $ | 1,443.1 | $ | 1,525.1 | $ | 1,525.1 | $ | 1,567.4 | $ | 1,551.5 | $ | 1,553.1 | ||||||||||
Asset valuation reserve (AVR) | 46.0 | 61.9 | 78.6 | 71.3 | 71.3 | 97.7 | 116.5 | 143.2 | ||||||||||||||||||
Capital, surplus and AVR | 1,464.5 | 1,496.6 | 1,521.7 | 1,596.4 | 1,596.4 | 1,665.1 | 1,668.0 | 1,696.3 | ||||||||||||||||||
Interest maintenance reserve (IMR) | 308.6 | 319.5 | 343.9 | 428.1 | 428.1 | 448.3 | 475.8 | 507.1 | ||||||||||||||||||
Total statutory capital, surplus, AVR & IMR | $ | 1,773.1 | $ | 1,816.1 | $ | 1,865.6 | $ | 2,024.5 | $ | 2,024.5 | $ | 2,113.4 | $ | 2,143.8 | $ | 2,203.4 | ||||||||||
&UP1SIT>7!E/2)04D]#15-3(B!X;7!'.G)E
M9#TB-C`B('AM<$ &UP1SIG
NDQ65Q*(9R?
MNH_\$H_V2",GT.>U7_C]S\2-!(_Y]8__`$:U=K\;O`'_``D6B'7=.A_XF>GH
M3(%',T(Y(]RO)'XCTKP34/$UUXCN?#RWQ+3Z?&EKYIZN@D)4GW`./PH`^H_B
M1XY@\"^&C>F-9KR=O*M86/#-C))_V0.OX#O7ED47QDU;P\?%B:X((FB-S%9J
M0C-&!G(3;MY'(!.34O[2D4_F^'I<'R`LZ^P?Y#_+^57M!^$]QKGAVROK+XB:
ML;6XMU*I'N*J".4QYG;ICVH`DTSXD:[XK^$NL7VGW"VOB'1]LDSQ1J1+'U+;
M2"!E0V?=?>NB^#OC>\\4^#[VXUJ[\Z]L9V$LI55_=E=RG``']X?A1\./AOI/
MA5M96UUQ=7CNE%I